Meta description: A university led trial assesses vibrational foam rolling versus standard foam rolling for self myofascial release, with regulatory implications for device aided therapy as of February 19, 2026.
In this regulatory news style update dated February 19, 2026, Celal Bayar University has announced a planned clinical study to examine two self myofascial release methods. The trial compares vibrational foam rolling and standard foam rolling using a device aided approach. The project is listed as not yet recruiting and is sponsored by the university. The information signals interest in how vibrating devices may influence tissue mobility and comfort during self care. Stakeholders in medical devices, clinical research, and regulatory teams should note the trial status and the potential implications for device based therapy in the field of physical therapy.
What is studied?
The study title shows two interventions: vibrational foam rolling and standard foam rolling. Both are described as self myofascial release methods. The sponsor is Celal Bayar University. The trial status is not yet recruiting. The aim is to generate regulatory grade information about the use of a device aided therapy for soft tissue mobility.
What is the regulatory context for this study?
This study sits at the intersection of therapy and medical device regulation. When a vibrating tool is used to assist a foam rolling technique, investigators must address device performance, safety, and risk management as part of the protocol. The not yet recruiting status indicates pending ethical and regulatory approvals and the need for sponsor oversight and proper documentation.
Who backs the study?
Celal Bayar University is named as the sponsor. This indicates university level oversight and access to institutional review processes. The record shows the project is currently not recruiting, which means no patient enrollment has started yet.
What is the plan for the trial design?
The study compares two interventions described as vibrational foam rolling and standard foam rolling, both used for self myofascial release. Details on sample size, endpoints, and blinding are not provided in the source text. The information highlights a device oriented approach that is in the early planning stage.
What safety considerations are noted?
The source text does not provide specific safety data. Standard practice requires risk assessment for devices used in self care. The trial would normally address how the device operates, user instructions, and any potential adverse effects as part of regulatory compliance.
- What is vibrational foam rolling and how does it differ from standard foam rolling?
- What is the status of the study?
- Who sponsors and where is the study conducted?
Conclusion
This announcement outlines a university sponsored trial to compare vibrational and non vibration foam rolling as a method of self myofascial release. The not yet recruiting status signals that regulatory steps and ethics review are in progress. Stakeholders in device development and clinical research should monitor for updates on design, safety findings and potential regulatory submissions.
Disclaimer
This article is intended for professionals and is not legal advice. Review regulatory documentation and seek counsel for jurisdiction specific requirements.
https://clinicaltrials.gov/study/NCT07414238?term=medical+device